M. Hebbar et al., CORRELATIONS BETWEEN ENDOTHELIAL E-SELECTIN EXPRESSION IN SALIVARY-GLANDS AND CLINICAL OR BIOLOGICAL FEATURES IN PATIENTS WITH SYSTEMIC-SCLEROSIS, La Revue de medecine interne, 19(8), 1998, pp. 537-541
Objectives. - A body of evidence suggests the pivotal role of endothel
ial cells in the pathophysiology of systemic sclerosis. E-selectin is
an adhesion molecule specifically expressed by activated endothelial c
ells. In previous studies we noticed that E-selectin was frequently ex
pressed in the salivary gland tissue of patients with systemic scleros
is. Moreover, E-selectin expression was detectable very early in the c
ourse of the disease. To better define the role of E-selectin in the p
athogenesis of systemic sclerosis, we conducted a study aimed at deter
mining whether E-selectin expression was correlated to clinical and bi
ological features in patients with systemic sclerosis. Methods. - Thir
ty-one patients presenting with systemic sclerosis were included in th
e study. The following parameters were systematically assessed: durati
on and cutaneous extent of the disease, presence of secondary Sjogren'
s syndrome, antinuclear antibodies, and pulmonary and esophagus involv
ement. E-selectin expression was assessed by immunocytochemistry on mi
nor labial salivary glands. Results. - E-selectin expression was detec
ted in 21 out of 31 patients (67%). The disease duration was significa
ntly shorter in patients with E-selectin expression (mean 9.1 +/- 8.5
years versus 4.2 +/- 3.3 years, P < 0.05). No significant difference w
as found for other features. Conclusions, - This study shows that endo
thelial E-selectin expression is mainly detectable early in the course
of systemic sclerosis, when active and non-cicatricial sclerosis may
be evidenced. No correlation was found between E-selectin expression a
nd immunological disorders (antinuclear antibodies, secondary Sjogren'
s syndrome). (C) 1998 Elsevier, Paris.